ePoster

IMPACT OF CLONAL HEMATOPOIESIS ON SECONDARY CARDIAC INJURY AFTER ISCHEMIC STROKE

Markus Winklerand 16 co-authors

Charité - Universitätsmedizin Berlin, Department of Experimental Neurology

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS04-08PM-092

Presentation

Date TBA

Board: PS04-08PM-092

Poster preview

IMPACT OF CLONAL HEMATOPOIESIS ON SECONDARY CARDIAC INJURY AFTER ISCHEMIC STROKE poster preview

Event Information

Poster Board

PS04-08PM-092

Abstract

Clonal haematopoiesis describes a clonal expansion of haematopoietic stem cells driven by mutations in epigenetic and DNA repair–associated genes, such as tet2. Patients carrying Tet2-CHIP have an increased risk for cardiovascular events. Stroke–heart syndrome refers to stroke-induced cardiac injury and dysfunction mediated by neurohumoral and inflammatory pathways. In this preclinical study, we aimed to analyse the impact of tet2-CHIP on stroke–heart syndrome.
Unilaterally irradiated mice reconstituted with either WT or tet2-knockout bone marrow were subjected to 30-min middle cerebral artery occlusion or sham surgery at 7 months of age. Using echocardiography, we analysed cardiac function and structure at baseline as well as on days 7 and 26 after ischaemic stroke. Troponin T levels were measured on days 7 and 28. Heart tissue underwent full spectrum flow cytometry based immunophenotyping after perfusion.
Echocardiographic data showed a reduction in ejection fraction and cardiac output exclusively in tet2-CHIP mice after stroke, which progressed over time. We observed indications of mild diastolic dysfunction alongside hypertrophic changes. These observations were accompanied by an expansion of Tet2-knockout leukocytes in the blood.
Our data suggest an exacerbated stroke–heart syndrome in tet2-CHIP mice following ischemic stroke, likely driven by proinflammatory changes associated with clonal haematopoiesis. Future interventional studies will evaluate immunomodulatory approaches to attenuate stroke-induced heart failure.

Recommended posters

IMPACT OF CLONAL HAEMATOPOIESIS ON THE INFLAMMATORY RESPONSE TO ISCHEMIC STROKE

Polina Bugaeva, Markus Winkler, Amido Daugardt, Sylwia Piatek, Laura Kate Ismajli, Jacqueline Keye, Desiree Kunkel, Susanne Mueller, Philipp Boehm-Sturm, Christian Hoffmann, Steffen Jung, Daniel Lewandowski, Anna Malik, Matthias Endres, Christoph Harms

DECIPHERING INFLAMMATORY MECHANISMS TO IMPROVE THE EFFICACY OF STEM CELL THERAPY

Marie Karam, Garrido santos Jose thomas, Tornero Daniel

CHARACTERIZATION OF A TRANSLATIONAL MOUSE MODEL OF STROKE INTEGRATING ATHEROSCLEROSIS AND CHRONIC NEUROIMMUNE DYSREGULATION

Pablo Vargas Rodríguez, Alejandro Cuenca Martagón, Julia Castillo González, Ignacio Serrano Martínez, Irene Forte Lago, Elena González Rey

SPATIAL CHARACTERIZATION OF MYELOID CELL HETEROGENEITY IN ISCHEMIC STROKE UNDER NORMOLIPIDEMIC AND HYPERLIPIDEMIC CONDITIONS

Leire Pedrosa, Nerea Chaparro-Cabanillas, Alba Simats, Davide Maspero, Anna Pascual-Reguant, Anna M. Planas

INFLUENCE OF NATURAL MICROBIOTA ON IMMUNE INFILTRATION AND MOTOR RECOVERY AFTER STROKE IN THE WILDLING MOUSE MODEL

Sylwia Piątek, Polina Bugaeva, Markus Winkler, Amelie Weber, Begüm Devlet Kilickap, Eduart Temaj, Laura Kate Ismajli, Tanja Specowius, Marco Foddis, Jacqueline Keye, Desiree Kunkel, Philipp Boehm-Sturm, Linda Hammerich, Stephan P. Rosshart, Christian Hoffmann, Christoph Harms

THE ASSESSMENT OF T2 MAP HETEROGENEITY WITHIN THE ISCHAEMIC AREA IDENTIFIES A NOVEL CEREBROPROTECTIVE ROLE OF SUBEROYLANILIDE HYDROXAMIC ACID FOLLOWING TMCAO

Andrea Díaz Pérez, Clara Penas, Francesc Jimenez-Altayó, Silvia Lope-Piedrafita

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.